Swiss drugmaker Novartis resumes Ukraine business
Add BT as a preferred source
DeeperDive is a beta AI feature. Refer to full articles for the facts.
NOVARTIS is resuming business in Ukraine after reviewing how safe it was to operate in the country that Russia invaded in February, the Swiss drugmaker said.
“After studying current safety protocols in the country, and on advice which we will regularly review, we have begun to resume business operations remotely to help the war-torn country restore some basic critical business processes,” Novartis said on its website in a post dated Jun 1.
“The safety and security of our people remains our number one objective, and we will constantly review the situation and our business operations in Ukraine.”
Novartis said it condemned the war in Ukraine and has been providing humanitarian support, financial donations and medicine to people there. Russia describes its invasion as a “special military operation” to disarm and “de-Nazify” its neighbour. REUTERS
Decoding Asia newsletter: your guide to navigating Asia in a new global order. Sign up here to get Decoding Asia newsletter. Delivered to your inbox. Free.
Share with us your feedback on BT's products and services
